Increased risk of serious pneumococcal disease in patients with asthma

Author(s): Juhn YJ, Kita H, Yawn BP, Boyce TG, Yoo KH, et al.

Abstract

Background: Individuals with asthma have been reported to be at increased risk of invasive pneumococcal disease (IPD). These findings need to be confirmed in a different population-based study setting.

Objective: We assessed whether serious pneumococcal disease (SPD), defined as an IPD, pneumococcal pneumonia, or both, was associated with asthma status.

Methods: This is a retrospective case-control study using criteria-based methods for ascertaining SPD, as well as asthma. Subjects were residents of Rochester, Minnesota, who had SPD between 1964 and 1983 (the primarily pre-pneumococcal vaccine era) and their age- and sex-matched control subjects using 1:2 matching. Potential cases and control subjects were identified by using the Rochester Epidemiology project database and confirmed by medical record reviews. All cases and control subjects were merged with the database comprising the entire pool of Rochester residents with and without asthma between 1964 and 1983.

Results: A total of 3941 records of potential patients with SPD were reviewed, and we identified 174 cases of SPD (51% male subjects and 94% white subjects). SPD was associated with a history of asthma among all ages (odds ratio, 2.4; 95% CI, 0.9-6.6; P = .09) and among adults (odds ratio, 6.7; 95% CI, 1.6-27.3; P = .01), controlling for high-risk conditions for IPD and smoking exposure. The population-attributable risk percentage was 17% in the adult population.

Conclusion: Adults with asthma might be at increased risk of SPD.

Similar Articles

Asthma as a risk factor for invasive pneumococcal disease

Author(s): Talbot TR, Hartert TV, Mitchel E, Halasa NB, Arbogast PG, et al.

Interobserver variability in medical record review: an epidemiological study of asthma

Author(s): Beard CM, Yunginger JW, Reed CE, O'Connell EJ, Silverstein MD

Accuracy of the death certificate in a population-based study of asthmatic patients

Author(s): Hunt LW Jr, Silverstein MD, Reed CE, O'Connell EJ, O'Fallon WM, et al.

Incidence and outcomes of asthma in the elderly

Author(s): Bauer BA, Reed CE, Yunginger JW, Wollan PC, Silverstein MD

Attained adult height after childhood asthma: effect of glucocorticoid therapy

Author(s): Silverstein MD, Yunginger JW, Reed CE, Petterson T, Zimmerman D, et al.

The influence of neighborhood environment on the incidence of childhood asthma: a multilevel approach

Author(s): Juhn YJ, Sauver JS, Katusic S, Vargas D, Weaver A, et al.

Childhood asthma and human leukocyte antigen type

Author(s): Juhn YJ, Kita H, Lee LA, Smith RW, Bagniewski SM, et al.

Allergic rhinitis in Rochester, Minnesota residents with asthma: frequency and impact on health care charges

Author(s): Yawn BP, Yunginger JW, Wollan PC, Reed CE, Silverstein MD, et al.

Childhood asthma and measles vaccine response

Author(s): Juhn YJ, Kita H, Lee LA, Swanson RJ, Smith R, et al.

Clinical characteristics and outcome of patients with invasive pneumococcal disease, Puy-de-Dôme, France, 1994-1998

Author(s): Laurichesse H, Romaszko JP, Nguyen LT, Souweine B, Poirier V, et al.

Airway inflammation and remodeling in asthma

Author(s): Fahy JV, Corry DB, Boushey HA

Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus

Author(s): Wark PA, Johnston SL, Bucchieri F, Powell R, Puddicombe S, et al.

Role of deficient type III interferon-lambda production in asthma exacerbations

Author(s): Contoli M, Message SD, Laza-Stanca V, Edwards MR, Wark PA, et al.

Humoral and cellular immunity in asthma

Author(s): Grove DI, Burston TO, Wellby ML, Ford RM, Forbes IJ

Antibody levels and response to pneumococcal vaccine in steroid-dependent asthma

Author(s): Lahood N, Emerson SS, Kumar P, Sorensen RU

Overexpression of interleukin-4 delays virus clearance in mice infected with respiratory syncytial virus

Author(s): Fischer JE, Johnson JE, Kuli-Zade RK, Johnson TR, Aung S, et al.

Influence of asthma status on serotype-specific pneumococcal antibody levels

Author(s): Jung JA, Kita H, Dhillon R, Jacobson RM, Nahm MH, et al.